David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Allegiant Air
ALGT
$2.25B
| $7.2M | 0.01% |
40,415
+11,708
| +41% | +$1.91M |
|
1027
Liberty Latin America Class A
LILA
$1.69B
| $7.18M | 0.01% |
319,714
| – | – |
|
|
NUAN
1028
DELISTED
Nuance Communications, Inc.
NUAN
| $7.17M | 0.01% |
443,269
-2,282,898
| -84% | -$36.9M |
|
|
LBY
1029
DELISTED
Libbey, Inc.
LBY
| $7.17M | 0.01% |
385,616
-38,693
| -9% | -$679K |
|
|
CSRA
1030
DELISTED
CSRA Inc.
CSRA
| $7.17M | 0.01% |
266,575
-32,300
| -11% | -$844K |
|
|
SCS
1031
DELISTED
Steelcase
SCS
| $7.16M | 0.01% |
480,164
+417,260
| +663% | +$5.55M |
|
1032
ABM Industries
ABM
$2.73B
| $7.16M | 0.01% |
221,525
+125,884
| +132% | +$3.8M |
|
1033
CALL
Adobe
ADBE
$109B
| $7.16M | 0.01% |
76,300
-117,400
| -61% | -$10.2M |
|
1034
Portland General Electric
POR
$5.86B
| $7.11M | 0.01% |
179,921
+147,903
| +462% | +$5.66M |
|
1035
QuidelOrtho
QDEL
$1.03B
| $7.1M | 0.01% |
411,139
-7,944
| -2% | -$133K |
|
1036
Energizer
ENR
$1.5B
| $7.09M | 0.01% |
175,148
-297,888
| -63% | -$10.9M |
|
|
PXD
1037
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $7.08M | 0.01% |
50,300
-125,200
| -71% | -$15.5M |
|
1038
MaxLinear
MXL
$6.02B
| $7.07M | 0.01% |
382,266
-62,429
| -14% | -$990K |
|
1039
Arbutus Biopharma
ABUS
$1.03B
| $7.07M | 0.01% |
1,711,569
-159,891
| -9% | -$571K |
|
|
FPRX
1040
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $7.06M | 0.01% |
173,823
-89,195
| -34% | -$3.07M |
|
|
ARIA
1041
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $7.06M | 0.01% |
1,104,998
-68,633
| -6% | -$385K |
|
|
S
1042
DELISTED
Sprint Corporation
S
| $7.06M | 0.01% |
2,027,529
+1,688,415
| +498% | +$5.39M |
|
|
HZNP
1043
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.06M | 0.01% |
425,817
-275,789
| -39% | -$4.83M |
|
1044
KT
KT
$9.16B
| $7.05M | 0.01% |
525,720
+454,136
| +634% | +$5.48M |
|
1045
Regis Corp
RGS
$66.8M
| $7.05M | 0.01% |
23,220
-2,995
| -11% | -$868K |
|
|
CSII
1046
DELISTED
Cardiovascular Systems, Inc.
CSII
| $7.05M | 0.01% |
679,860
+44,508
| +7% | +$451K |
|
|
CMBT
1047
CMB.TECH NV
CMBT
$5.27B
| $7.05M | 0.01% |
688,378
+283,722
| +70% | +$3.06M |
|
|
SWC
1048
DELISTED
Stillwater Mining Co
SWC
| $7.04M | 0.01% |
661,463
-101,613
| -13% | -$813K |
|
1049
CALL
Newmont
NEM
$142B
| $7.04M | 0.01% |
265,000
+215,000
| +430% | +$4.98M |
|
|
LL
1050
DELISTED
LL Flooring Holdings, Inc.
LL
| $7.01M | 0.01% |
534,377
+160,168
| +43% | +$2.02M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.